Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 90/100

Failure Rate

33.3%

2 terminated/withdrawn out of 6 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT03651076Not ApplicableTerminated

Traxi Panniculus Retractor for Cesarean Delivery

Role: collaborator

NCT02208011Completed

A Comparison of Rapid Immunoassays for the Detection of Ruptured Membranes

Role: collaborator

NCT02648867Not ApplicableTerminated

Evaluation of Maternal Feedback to Shorten Pushing Efforts During Labor

Role: lead

NCT02524691Unknown

Efficacy Study of Rapid Immunoassay Diagnostic Test Utilizing PP12 and AFP, ROM Plus

Role: lead

NCT02495441Unknown

Rapid Immunoassay Tests for the Detection of Ruptured Membranes

Role: collaborator

NCT01366443Completed

Analysis of ROM Plus to Detect Rupture of Membranes

Role: lead

All 6 trials loaded